Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and MI for Schizophrenic Smokers
NCT00781755Phase 4Withdrawn
- Sponsor
- VA Boston Healthcare System
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of varenicline in Tobacco Use Disorder (TUD) (2 arms), sponsored by VA Boston Healthcare System. Primary endpoints: Reported Smoking Urge and Withdrawal at 2 weeks, Number of cigarettes smoked per day at 2 weeks and 2 more. Status: withdrawn.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00781755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781755.